AARTI DRUGS LTD. (AARTIDRUGS)

NSE: ₹374.85
BSE: ₹375.05
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation of Analyst/Institutional Investor meet

2026-06-05 13:00:16
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the financial year ended March 31, 2026

2026-05-26 20:55:47
Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Q4 & FY26 Earning Call Transcript

2026-05-23 23:35:50
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation of Analyst Meet

2026-05-22 15:11:45
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audit Recording of Q4 and FY26 Earning Conference Call

2026-05-18 16:01:56
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Financial Results

2026-05-18 15:57:29
Announcement under Regulation 30 (LODR)-Investor Presentation

Q4 and FY26 Investor Presentation

2026-05-16 14:46:25
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Q4 and FY26 Business and Financial Performance

2026-05-16 14:40:23
Re-Appointment Of Cost Auditor And Internal Auditor

Re-appointment of Cost Auditor and Internal Auditor

2026-05-15 18:55:24
Board Meeting Outcome for Outcome Of The Board Meeting Dated May 15, 2026

Outcome of the Board Meeting - Financial Results, Re-Appointment of Internal Auditor and Cost Auditor, Reconstitute of Risk Management Committee

2026-05-15 18:45:05

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 661.11 641.54 605.94 619.99 590.51 598.33 556.60 676.76 590.51 652.79 601.71 720.30
YOY Revenue Growth % 6.29% -6.71% -8.74% -16.49% -10.68% -6.74% -8.14% 9.16% 0% 9.1% 8.1% 6.43%
Other Income 0.60 0.68 1.67 1.08 0.31 1.48 11.90 1.87 0.31 0.09 1.23 0.76
Total Income 661.71 642.22 607.61 621.07 590.82 599.81 568.50 678.63 590.82 652.88 602.94 721.06
Total Expenses + 598.18 585.95 556.06 556.89 539.71 553.93 517.74 607.48 539.71 592.47 573.92 650.70
Cost of Materials Consumed 408.61 395.66 401.07 366.64 357.25 345.58 369.79 375.14 357.25 385.06 334.52 427.19
Employee Benefit Expense 25.47 25.45 25.55 25.87 30.80 26.56 27.76 31.35 30.80 33.07 33.16 32.28
Other Expenses 105.22 110.61 105.02 111.21 112.24 110.72 115.72 115.18 112.24 127.15 126.88 141.80
Operating Profit 62.93 55.59 49.88 63.10 50.80 44.40 38.86 69.28 50.80 60.32 27.79 69.60
OPM % 9.5% 8.7% 8.2% 10.2% 8.6% 7.4% 7% 10.2% 8.6% 9.2% 4.6% 9.7%
Profit Before Tax + 63.53 56.27 51.55 64.18 51.11 45.88 50.76 71.15 51.11 60.41 29.02 70.36
Tax Expense 15.56 16.67 14.84 16.87 -2.86 10.92 13.67 8.38 -2.86 15.25 -11.53 15.10
Tax % 24.5% 29.6% 28.8% 26.3% -5.6% 23.8% 26.9% 11.8% -5.6% 25.2% -39.7% 21.5%
Profit After Tax 47.97 39.60 36.71 47.31 53.97 34.96 37.09 62.77 53.97 45.16 40.55 55.26
EPS (Basic) 5.18 4.29 3.99 5.15 5.91 3.83 4.06 6.88 5.91 4.95 4.44 6.05

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 2,565.31 2,387.03 2,528.58 2,716.05 2,488.65 2,154.78 1,806.09
YOY Revenue Growth % 7.47% -5.6% -6.9% 9.14% 15.49% 19.31% -
Other Income 2.39 16.36 4.03 2.19 11.32 4.53 1.48
Total Income 2,567.70 2,403.39 2,532.61 2,718.24 2,499.97 2,159.31 1,807.57
Total Expenses + 2,356.80 2,191.62 2,297.08 2,494.06 2,230.01 1,790.52 1,507.23
Cost of Materials Consumed 1,504.01 1,438.30 1,571.98 1,768.97 1,666.36 1,221.52 1,141.92
Employee Benefit Expense 129.32 112.10 102.34 92.02 82.81 80.50 69.36
Other Expenses 508.08 445.77 432.05 429.92 387.55 316.14 295.95
Operating Profit 208.51 195.41 231.50 221.99 258.64 364.26 298.86
OPM % 8.1% 8.2% 9.2% 8.2% 10.4% 16.9% 16.5%
Profit Before Exceptional 210.90 211.77 235.53 224.18 269.96 368.79 180.82
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.22 4.47
Profit Before Tax + 210.90 211.77 235.53 224.18 269.96 369.01 185.29
Tax Expense 15.96 43.67 63.94 57.82 64.96 88.61 43.89
Tax % 7.6% 20.6% 27.1% 25.8% 24.1% 24% 23.7%
Profit After Tax 194.94 168.10 171.59 166.36 205.00 280.40 141.40
EPS (Basic) 21.36 18.35 18.56 17.97 22.12 30.09 60.57

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 1,347.49 1,236.32 1,111.64 929.04 814.59 709.22 0.00
Property, Plant & Equipment 1,068.27 856.25 808.16 675.43 685.69 659.25 0.00
Capital Work in Progress 213.81 330.18 225.23 210.35 76.74 19.26 0.00
Non-Current Investments 27.31 22.41 19.97 18.80 19.48 17.30 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 16.43 7.15 1.18 0.79 0.15 0.26 0.00
Current Assets + 1,467.77 1,338.36 1,320.72 1,492.36 1,393.37 1,056.79 0.00
Inventories 490.78 472.93 485.89 516.29 525.94 415.00 0.00
Trade Receivables 829.87 751.18 704.55 864.84 749.90 555.23 0.00
Cash and Cash Equivalents 7.27 4.58 6.74 8.96 22.33 9.78 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 1,549.23 1,369.34 1,281.96 1,192.66 1,036.30 913.41 0.00
Equity Share Capital 91.27 91.27 91.94 92.60 92.60 93.20 0.00
Other Equity 1,457.59 1,277.73 1,189.61 1,099.83 943.76 820.22 0.00
Non-Current Liabilities 343.78 368.37 354.86 295.76 231.60 257.24 0.00
Current Liabilities 922.25 836.97 795.54 932.98 940.06 595.36 0.00
Total Liabilities 1,266.03 1,205.34 1,150.40 1,228.74 1,171.66 852.60 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 253.54 244.58 358.92 134.20 69.64 154.84 0.00
Cash from Investing Activities -173.41 -164.63 -223.65 -163.97 -148.86 -71.68 0.00
Cash from Financing Activities -77.44 -82.12 -136.03 16.54 92.02 -81.12 0.00
Net Increase/Decrease in Cash 2.69 -2.17 -0.76 -13.23 12.80 2.04 0.00